Activation of the PI3K/AKT pathway (through mutation of PIK3CA and AKT or inactivating mutations of PTEN) is a frequent event in clear-cell and endometrioid ovarian cancers. Here, AKT1 is linked to ovarian endometrioid adenocarcinoma.